PHIRI - WP6 - Use Case B outputs from the local analyses (interactive reports)

The PHIRI Federated Research Infrastructure (FRI) is supported by a containerized reproducible solution for data analysis (i.e. use cases) to be deployed on-premises by each participant partner (a.k.a PHIRI-app) to generate a set of local results (outputs) to be further analysed and interpreted generating relevant insight for health policy. 

This use case will seek to elicit whether there has been an increase in time to treatment in women diagnosed with breast cancer in the month previous to the lockdown measures, as compared with the woman diagnosed with breast cancer before that period and whether the distribution of this delay could be influenced by the healthcare reorganisation measures due to the COVID pandemic.

Health Systems across Europe had to reorganise healthcare services reallocating resources towards providing complex assistance to COVID-19 patients. COVID-19 surge of cases during the different epidemic waves requiring intensive care has led countries to cancel or postpone non-urgent care (i.e. elective surgery).

The present outputs correspond to the analyses of four nodes that completed the deployment of the analytical pipeline in their premises (Belgium (BE), Wales (UK), Marche (IT), and Aragon (ES)).

Others are still ongoing; so, Latvia is reviewing some errors in their dataset; in turn, Croatia, Estonia and Slovenia showed availability for the deployment of the use case.

The outputs from the local analyses in those countries include:

- Interactive joint report of the trends in diagnosis and delayed treatment for breast cancer (HTLM)

- Compilation of the local reports for each country (ZIP file containing HTML documents)

- Compilation of the Data Quality Analysis reports for the original data in each country (ZIP file containing HTML documents)